EnBiotix is a bioengineering company commercializing anti-infective inventions of co-founder and SAB Chair Professor James J. Collins. Through breakthrough systems and synthetic biology platforms, EnBiotix is transforming and revitalizing existing antibiotic classes to combat the global rise of drug-resistant bacterial infections.

TCG is an international life science consulting firm with offices in the US and Europe that serves life science companies in medical device, diagnostics, pharmaceutical, biotechnology, and other health care markets. The firm provides interim management for companies needing an experienced executive to lead a critical project, enter a new market, develop a new strategy, or refocus a company. TCG also leads strategic transactions, including licensing, strategic partnerships, commercialization and distribution agreements, asset sales, and acquisitions.